glaucoma eye

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye. (Credit: Rob Felt, Georgia Tech)

LONDON — Some of the United Kingdom’s most famous paintings have been altered – to show what they’d look like to someone with glaucoma. Pieces by masters Sandro Botticelli and Thomas Gainsborough, among others, have been changed to show how they would appear to people with the devastating eye condition.

Each of the artworks, including “The Supper at Emmaus” (1601) by Michelangelo Merisi da Caravaggio, can be found at London’s National Gallery. However, researchers are showing them with blurring around the edges and missing details, replicating how they could appear to people dealing with this leading cause of vision loss.

Michelangelo Merisi da Caravaggio, The Supper at Emmaus - Normal.
Michelangelo Merisi da Caravaggio, The Supper at Emmaus – Normal Vision. (Credit: SWNS)
Michelangelo Merisi da Caravaggio, The Supper at Emmaus - Advanced Glaucoma.
Michelangelo Merisi da Caravaggio, The Supper at Emmaus – Advanced Glaucoma. (Credit: SWNS)

Glaucoma is the leading cause of irreversible vision loss worldwide, currently affecting 80 million people total and 3 million people in the United States,” according to the National Institutes of Health.

“Seeing the loss of details in these famous artworks highlights just what an impact this condition can have, not just when viewing beautiful art, but also in your day-to-day life,” says Giles Edmonds, the clinical services director at Specsavers, which led the project. “Having an eye test at least every two years, regardless of age, vision issues or symptoms, is so important as this condition is treatable and it is possible to prevent potential sight loss, or even irreversible blindness.”

Other pieces of priceless art that were altered include “Bathers at Asnières” (1884) by Georges Seurat and “The Ambassadors” (1533) by Hans Holbein the Younger.

Georges Seurat, Baters at Asnieres, 1884 - Normal Vision.
Georges Seurat, Bathers at Asnieres, 1884 – Normal Vision. (Credit: SWNS)
Georges Seurat, Baters at Asnieres, 1884 - Advanced Glaucoma.
Georges Seurat, Bathers at Asnieres, 1884 – Advanced Glaucoma. (Credit: SWNS)

Glaucoma is a common eye condition where the optic nerve between the eye and the brain becomes damaged and is usually detected through a routine eye test. The condition, often referred to as the “silent thief of sight,” can be present without any symptoms, with almost half of those living with the condition being unaware that they have it.

Thomas Gainsborough, Mr. & Mrs. Andrews 1750 - Normal Vision.
Thomas Gainsborough, Mr. & Mrs. Andrews 1750 – Normal Vision. (Credit: SWNS)
Thomas Gainsborough, Mr. & Mrs. Andrews 1750 - Advanced Glaucoma.
Thomas Gainsborough, Mr. & Mrs. Andrews 1750 – Advanced Glaucoma. (Credit: SWNS)

“This lends a crucial reminder to everyone about the importance of getting regular sight tests, to continue to enjoy not only their favorite artworks but also to detect early signs of conditions such as glaucoma,” says Tracy Jones from the National Gallery.

“Thankfully, the National Gallery offers a range of accessible facilities to help the public experience the collection, visit exhibitions, and come to events,” Jones continues. “Designed specifically for blind and partially sighted audiences, these events explore paintings on multi-dimensional levels – through words, music, and sounds.”

SWNS writer Richard Jenkins contributed to this report.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

Chris Melore

Editor

Sophia Naughton

Associate Editor